Regulation of aldosterone secretion

Current Opinion in Endocrinology and Diabetes

Volumn 3, Issue 3, 1996, Pages 248-257

  Capponi, Alessandro M ^a   Rossier, Michel F ^a  

^a University Hospitals   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001548291     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199606000-00010     Document Type: Article

References (78)

1. Simpson SA, Tait JF, Wettstein A, Neher R, von Euw J, Reichstein T: Isolierung eines neuen kristallisierten Hormons aus Nebennieren mit besonders hoher Wirksamkeit auf den Mineralstoffwechsel [in German]. Experientia 1953, 9:333.
2. Müller J: Aldosterone: the minority hormone of the adrenal cortex. Steroids 1995, 60:2-9. By the author of the most comprehensive textbook on the regulation of aldosterone biosynthesis, this brief review focuses principally on the enzymology of the final steps of this cascade.
3. Capponi AM, Python CP, Rossier MF: Molecular basis of anglotensin II action on mineralocorticoid synthesis. Endocrine 1994, 2:579-586.
4. Ganguly A, Davis JS: Role of calcium and other mediators in aldosterone secretion from the adrenal glomerulosa cells. Pharmacol Rev 1994, 46:417-447.
5. Vallotton MB, Rossier MF, Capponi AM: Potassium-anglotensin interplay in the regulation of aldosterone biosynthesis. Clin Endocrinol 1995, 42:111-119. A review examining the clinical observations, the in vivo human and animal studies, and the in vitro data that may explain the complex, at times even opposing, interaction between angiotensin II and potassium.
6. 2+ influx, and protein kinase C activation in sustained cellular responses. Endocrine Rev 1995, 16:649-681.
7. Müller J: Regulation of Aldosterone Biosynthesis: Physiological and Clinical Aspects, edn 2. Berlin: Springer-Verlag; 1988.
8. Vinson GP, Hinson JP, Toth IE: The neuroendocrinology of the adrenal cortex. J Neuroendocrinol 1994, 6:235-246. A much-needed and well-documented review of the neural regulation of adrenocortical function, stressing the importance of indirect paths involving the vasculature of the gland.
9. Yon L, Chartrel N, Feuilloley M, Demarchis S, Fournier A, Derijk E, Pelletier G, Roubos E, Vaudry H: Pituitary adenylate cyclase-activating polypeptide stimulates both adrenocortical cells and chromaffin cells in the frog adrenal gland. Endocrinology 1994, 135:2749-2758.
10. Guillon G, Trueba M, Joubert D, Grazzini E, Chouinard L, Cöté M, Payet MD, Manzoni O, Barberis C, Robert M, Gallot-Payet N: Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect Endocrinology 1995, 136:1285-1295.
11. Mazzocchi G, Macchi C, Malendowicz LK, Nussdorfer GG: Evidence that endogenous substance-P (SP) is involved in the maintenance of the growth and steroidogenic capacity of rat adrenal zona glomerulosa. Neuropeptides 1995, 29:53-58.
12. Lefebvre H, Contesse V, Delarue C, Legrand A, Kuhn JM, Vaudry H, Wolf LM: The serotonin-4 receptor agonist cisapride and anglotensin-II exert additive effects on aldosterone secretion in normal man. Endocrinology 1995, 80:504-507.
13. Ganten D, Hermann K, Unger TH, Lang RE: The tissue renin-angiotensin system: focus on brain angiotensin, adrenal gland and arterial wall. Clin Exp Hypertens 1983, A5:1099-1118.
14. Chiou CY, Kifor I, Moore TJ, Williams GH: The effect of losartan on potassium-stimulated aldosterone secretion in vitro. Endocrinology 1994, 134:2371-2375.
15. Gupta P, Franco-Saenz R, Mulrow PJ: Locally generated angiotensin II in the adrenal gland regulates basal, corticotropin- and potassium-stimulated aldosterone secretion. Hypertension 1995, 25:443-448.
16. Kifor I, Moore TJ, Fallo F, Sperling E, Chiou CY, Menachery A, Williams GH: Potassium-stimulated angiotensin release from superfused adrenal capsules and enzymatically dispersed cells of the zona glomerulosa. Endocrinology 1991, 129:823-831.
17. Mullins JJ, Peters J, Ganten O: Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990, 344:541-544.
18. Rebuffat P, Rocco S, Andreis PG, Neri G, Nowak KW, Peters J, Opocher G, Mazzocchi G, Mantero F, Nussdorfer GG: Morphology and function of the adrenal zona glomerulosa of transgenic rats TGR[mREN2]27: effects of prolonged sodium restriction. J Steroid Biochem Mol Biol 1995, 54:155-162.
19. Rocco S, Rebuttal P, Cimolato M, Opocher G, Peters J, Mazzocchi G, Ganten D, Mantero F, Nussdorfer GG: Zona glomerulosa of the adrenal gland in a transgenic strain of rat: a morphologic and functional study. Cell Tissue Res 1994, 278:21-28.
20. Rubattu S, Enea I, Ganten D, Salvatore D, Condorelli G, Russo R, Romano M, Gigante B, Trimarco B, Volpe M: Enhanced adrenal renin and aldosterone biosynthesis during sodium restriction in TGR (mREN2)27. Am J Physiol 1994, 30:E515-E520.
21. Volpe M, Rubattu S, Gigante B, Ganten O, Porcellini A, Russo R, Romano M, Enea I, Lee MA, Trimarco B: Regulation of aldosterone biosynthesis by adrenal renin is mediated through AT(1) receptors in renin transgenic rats. Circ Res 1995, 77:73-79.
22. Lopez MJ, Wong SKF, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, Beuve A: Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 1995, 378:65-68. An elegant study of ANP receptor gene knockout. The phenotype is reminiscent of some forms of salt-resistant hypertension in humans and may suggest that these disease states are due to ANP receptor gene defects.
23. Redmann A, Mobius K, Hiller HH, Oelkers W, Bahr V: Ascorbate depletion prevents aldosterone stimulation by sodium deficiency in the guinea pig. Eur J Endocrinol 1995, 133:499-506. A combined in vivo and in vitro study clearly demonstrating the crucial role of ascorbic acid in the maintenance of the aldosterone response to sodium restriction.
24. Ni HP, Mune T, Morita H, Daidoh H, Hanafusa J, Shibata T, Yamakita N, Yasuda K: Inhibition of aldosterone turn-off phenomenon following chronic adrenocorticotropin treatment with in vivo administration of antiglucocortlcoid and antioxidants in rats. Eur J Endocrinol 1995, 133:578-584. A nice in vivo and in vitro demonstration of the permissive effect of vitamin E on aldosterone synthesis, which is one of the possible explanations for the phenomenon of aldosterone turnoff. In conjunction with Redmann et al. (Eur J Endocrinol 1995, 133:499-506), this paper attributes a prominent role to antioxidant vitamins in mineralocorticoid synthesis.
25. Seely EW, Conlin PR, Brent GA, Dluhy RG: Adrenocorticotropin stimulation of aldosterone: prolonged continuous versus pulsatile infusion. J Clin Endocrinol Metab 1989, 69:1028-1032.
26. Schnell DA, Vari RC, Samson WK: Adrenomedullin: a newly discovered hormone controlling fluid and electrolyte homeostasis. Trends Endocrinol Metab 1996, 7:7-13.
27. Yamaguchi T, Baba K, Doi Y, Yano K: Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells. Life Sci 1994, 56:379-387.
28. Kapas S, Catt KJ, Clark AJL: Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J Biol Chem 1995, 270:25344-25347.
29. Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R Yamamoto H: Vascular aldosterone: biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 1994, 269:24316-24320.
30. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh FY, Takeda R: Production of aldosterone in isolated rat blood vessels. Hypertension 1995, 25:170-173.
31. Wehling M: Nongenomic actions of steroid hormones. Trends Endocrinol Metab 1994, 5:347-353.
32. McKenna TJ: The diagnosis and management of primary aldosteronism. Curr Opin Endocrinol Diabetes 1995, 2:194-202. An excellent summary of the current approach to the diagnosis and treatment of primary aldosteronism. It presents a useful algorithm that may help the practitioner in investigating such cases.
33. Litchfield WR, Dluhy RG: Primary aldosteronism. Endocrinol Metab Clin North Am 1995, 24:593-612. This is a comprehensive synthesis on primary aldosteronism, spanning from clinical features to the differential diagnosis and treatment. The detailed description of the various screening, hormonal, and radiologic tests makes it an invaluable tool for clinicians.
34. Baukal AJ, Hunyady L, Catt KJ, Balla T: Evidence for participation of calcineurin in potentiation of agonist-stimulated cyclic AMP formation by the calcium-mobilizing hormone, angiotensin II. J Biol Chem 1994, 269:24546-24549.
35. de Gasparo M, Husain A, Alexander W, Catt KJ, Chiu AT, Drew M, Goodfriend T, Harding JW, Inagami T, Timmermans PBMWM: Proposed update of angiotensin receptor nomenclature. Hypertension 1995, 25:924-927.
36. Bird IM, Word RA, Clyne C, Mason JI, Rainey WE: Potassium negatively regulates angiotensin II type 1 receptor expression in human adrenocortical H295R cells. Hypertension 1995, 25:1129-1134.
37. Boulay G, Chretien L, Richard DE, Guillemette G: Short-term desensitization of the angiotensin II receptor of bovine adrenal glomerulosa cells corresponds to a shift from a high to a low affinity state. Endocrinology 1994, 135:2130-2136.
38. Kapas S, Hinson JP, Puddefoot JR, Ho MM, Vinson GP: Internalization of the type I angiotensin II receptor (AT1) is required for protein kinase C activation but not for inositol trisphosphate release in the angiotensin II stimulated rat adrenal zona glomerulosa cell. Biochem Biophys Res Commun 1994, 204:1292-1298.
39. 2+ response in rat adrenal glomerulosa cells. Am J Physiol 1994, 266:C67-C72.
40. Spät A, Rohacs T, Hunyady L: Plasmalemmal dihydropyridine receptors modify the function of subplasmalemmal inositol 1,4,5-trisphosphate receptors: a hypothesis. Cell Calcium 1994, 15:431-437.
41. Burnay MM, Python CP, Vallotton MB, Capponi AM, Rossier MF: Role of the capacitative calcium influx in the activation of steroidogenesis by angiotensin II in adrenal glomerulosa cells. Endocrinology 1994, 135:751-758.
42. 2+ influx in adrenal glomerulosa cells: possible role in angiotensin II response. Am J Physiol 1994, 36:C1246-C1252.
43. 2+ antagonists should be used when attempting to therapeutically control aldosterone secretion.
44. Kocsis JF, Schimmel PJ, Mcilroy PJ, Carsia RV: Dissociation of increases in intracellular calcium and aldosterone production induced by angiotensin II (AII): evidence for regulation by distinct AII receptor subtypes or isomorphs. Endocrinology 1995, 136:1626-1634.
45. Osipenko ON, Varnai P, Mike A, Spät A, Vizi ES: Dopamine blocks T-type calcium channels in cultured rat adrenal glomerulosa cells. Endocrinology 1994, 134:511-514.
46. McCarthy RT, Isales C, Rasmussen H: T-type calcium channels in adrenal glomerulosa cells: GTP-dependent modulation by angiotensin-II. Proc Natl Acad Sci U S A 1993, 90:3260-3264.
47. 2+ channels by calmodulin-dependent protein kinase II. Am J Physiol 1994, 267:F183-F189.
48. Rossier MF, Aptel HBC, Python CP, Burnay MM, Vallotton MB, Capponi AM: Inhibition of low threshold calcium channels by angiotensin II in adrenal glomerulosa cells through activation of protein kinase C. J Biol Chem 1995, 270:15137-15142.
49. Python CP, Laban OP, Rossier MF, Vallotton MB, Capponi AM: The site of action of calcium in the activation of steroidogenesis: studies in calcium-clamped bovine adrenal glomerulosa cells. Biochem J 1995, 305:569-576.
50. Varnai P, Osipenko ON, Vizi ES, Spät A: Activation of calcium current in voltage-clamped rat glomerulosa cells by potassium ions. J Physiol 1995, 483:67-78.
51. + channels in adrenal zona glomerulosa cells: I: characterization of distinct channel types. Am J Physiol 1992, 263:E752-E759.
52. Stern N, Yanagawa N, Saito F, Hori M, Natarajan R, Nadler J, Tuck M: Potential role of 12-hydroxyeicosatetraenoic acid in angiotensin II-induced calcium signal in rat glomerulosa cells. Endocrinology 1993, 133:843-847.
53. Gu JL, Natarajan R, Benezra J, Valente G, Scott S, Yoshimoto T, Yamamoto S, Rossi JJ, Nadler JL: Evidence that a leukocyte type of 12-lipoxygenase is expressed and regulated by angiotensin II in human adrenal glomerulosa cells. Endocrinology 1994, 134:70-77.
54. Natarajan R, Kathuria S, Lanting L, Gonzales N, Nadler J: Differential short- and long-term effects of insulin on Ang II action in human adrenal glomerulosa cells. Am J Physiol 1995, 268:E100-E106.
55. Ganguly A, Li L, Haxton M: Inhibition of angiotensin II- and potassium-mediated aldosterone secretion by KN-62 suggests involvement of CA(2+)-calmodulin dependent protein kinase II in aldosterone secretion. Biochem Biophys Res Commun 1995, 209:916-920.
56. 2+/calmodulin-dependent protein kinase II inhibitor, on adrenocortical cell aldosterone production. Endocrine Res 1995, 21:259-265.
57. Kojima I, Kawamura N, Shibata H: Rate of calcium entry determines the rapid changes in protein kinase C activity in angiotensin II-stimulated adrenal glomerulosa cells. Biochem J 1994, 297:523-528.
58. Kojima I, Kojima K, Kreutter D, Rasmussen H: The temporal integration of the aldosterone secretory response to angiotensin occurs via two intracellular pathways. J Biol Chem 1984, 259:14448-14457.
59. Hajnóczky G, Varnai P, Buday L, Farago A, Spät A: The role of protein kinase-C in control of aldosterone production by rat adrenal glomerulosa cells: activation of protein kinase-C by stimulation with potassium. Endocrinology 1992, 130:2230-2236.
60. Ganguly A, Waldron C: Comparative effects of a highly specific protein kinase C inhibitor, calphostin C and calmodulin inhibitors on angiotensin-stimulated aldosterone secretion. J Steroid Biochem Mol Biol 1994, 50:253-260.
61. Kapas S, Purbrick A, Hinson JP: Role of tyrosine kinase and protein kinase C in the steroidogenic actions of angiotensin II, alpha-melanocyte-stimulating hormone and corticotropin in the rat adrenal cortex. Biochem J 1995, 305:433-438.
62. Capponi AM, Rossier MF, Davies E, Vallotton MB: Calcium stimulates steroidogenesis in permeabilized bovine adrenal cortical cells. J Biol Chem 1988, 263:16113-16117.
63. King SR, Ronenfuhrmann T, Timberg R, Clark BJ, Orly J, Stocco DM: Steroid production after in vitro transcription, translation, and mitochondrial processing of protein products of complementary deoxyribonucleic acid for steroidogenic acute regulatory protein. Endocrinology 1995, 136:5165-5176. A clear demonstration of the maturation pathway of the StAR protein from the cytosol to the mitochondria, which must occur in order for an activation of steroidogenesis to take place.
64. scc. This paper is accompanied by a short note stressing the importance of this finding (Science 1995, 267:1780-1781).
65. + in H295R adrenocortical cells. Mol Cell Endocrinol 1995, 115:215-219.
66. 2+ and by GTP. Mol Cell Endocrinol 1995, 107:181-188.
67. 2+. Arch Biochem Biophys 1995, 318:131-139.
68. Waterman MR: Biochemical diversity of cAMP-dependent transcription of steroid hydroxylase genes in the adrenal cortex. J Biol Chem 1994, 269:27783-27786.
69. Corvol P, Soubrier F, Jeunemaître X: Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension. Curr Opin Endocrinol Diabetes 1995, 2:266-275. A state-of-the art document reviewing the known gene abnormalities in the renin-angiotensin-aldosterone system and describing the phenotypes that are associated with these mutations. A window opening on treatments of the next century.
70. Vinson GP, Reja R, Ho MM, Puddefoot JR: A two cell type theory for aldosterone biosynthesis: the roles of 11β-hydroxylase and aldosterone synthase, and a high capacity tightly binding steroid carrier for 18-hydroxycorticosterone in rat adrenals. J Endocrinol 1995, 144:359-368.
71. Zhou MY, Xue D, Foecking MF, Gomezsanchez CE: Stable expression of rat cytochrome P450 11 beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) in MA-10 cells. J Steroid Biochem Mol Biol 1995, 52:523-528.
72. Takemori S, Kominami S, Yamazaki T, Ikushiro S: Molecular mechanisms of cytochrome P-450-dependent aldosterone biosynthesis in the adrenal cortex. Trends Endocrinol Metab 1995, 6:267-273. An excellent and easily understandable review on the quite complex genetics of aldosterone synthase, highlighting the two models of aldosterone biosynthesis in mammals: the rodent-human and the bovine-porcine models.
73. Raff H, Jankowski B: O-2 dependence of pregnenolone and aldosterone synthesis in mitochondria from bovine zona glomerulosa cells. J Appl Physiol 1995, 78:1625-1628.
74. Goodfriend TL, Lee WM, Ball DL, Elliott ME: Specificity and mechanism of fatty acid inhibition of aldosterone secretion. Prostaglandins Leukot Essent Fatty Acids 1995, 52:145-149.
75. Cover CM, Wang JM, Stlezin E, Kurtz TW, Mellon SH: Molecular variants in the P450c11AS gene as determinants of aldosterone synthase activity in the Dahl rat model of hypertension. J Biol Chem 1995, 270:16555-16560.
76. Fardella CE, Rodriguez H, Hum DW, Mellon SH, Miller WL: Artificial mutations in P450C11AS (aldosterone synthase) can increase enzymatic activity: a model for low-renin hypertension? Endocrinology 1995, 80:1040-1043.
77. 11β by 18-unsaturated progesterone derivatives. Eur J Biochem 1995, 232:247-256.
78. Waterman MR: A rising StAR: an essential role in cholesterol transport. Science 1995, 267:1780-1781.